Trades on 2 secondary markets

Orbital Therapeutics

Orbital Therapeutics was a Cambridge, Massachusetts biotechnology company developing next-generation RNA medicines, combining circular and linear RNA, targeted delivery, and AI-guided design across immunomodulation, in vivo CAR-T cell therapy, next-generation vaccines, and protein therapeutics. Its

minimal 5.7 / 100 0 APIs View provider profile →

Company Biotechnology Pharmaceuticals RNA Medicines Cell Therapy Life Sciences

Orbital Therapeutics is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.